GLAUKOS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.48 USD | -0.63% |
|
+3.09% | +25.15% |
| 04-11 | Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating | MT |
| 04-11 | Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing | MT |
Chart calendar Glaukos Corporation
5ec760d2ba7d34898a.sUYmjx56sD5l6HZp8N53108pJRqWH_hmaKuav6CMvWI.iCJp2FE84ggpxScrxqstpz8RcGr1dpQzUc7siOj5-gvLNkzqfBvaZiu5FQ~4842a46fd6247497566ba3f0d9b8d9a2
Upcoming events on Glaukos Corporation
Past events on Glaukos Corporation
| 21/02/2024 21:30 | Q4 2023 Earnings Call |
| 21/02/2024 21:05 | Q4 2023 Earnings Release |
| 10/01/2024 01:15 | JPMorgan Healthcare Conference |
| 14/12/2023 13:30 | IDose®TR FDA Approval Call |
| 14/11/2023 15:55 | Stifel Healthcare Conference |
| 04/11/2023 17:00 | American Academy Of Ophthalmology Meeting |
| 03/11/2023 20:53 | American Academy Of Ophthalmology Meeting |
| 01/11/2023 20:30 | Q3 2023 Earnings Call |
| 01/11/2023 20:05 | Q3 2023 Earnings Release |
| 06/09/2023 17:45 | Wells Fargo Healthcare Conference |
| 02/08/2023 21:30 | Q2 2023 Earnings Call |
| 02/08/2023 21:05 | Q2 2023 Earnings Release |
| 07/06/2023 16:40 | William Blair Growth Stock Conference |
| 01/06/2023 17:00 | Annual General Meeting |
| 07/05/2023 23:47 | The American Society of Cataract & Refractive Surgery Meeting - Kenneth A. Beckman, MD |
| 07/05/2023 22:11 | The American Society of Cataract & Refractive Surgery Meeting - Philip Dockery, MD |
| 07/05/2023 21:51 | The American Society of Cataract & Refractive Surgery Meeting - Miltos Balidis, Ph.D., MD |
| 07/05/2023 21:45 | The American Society of Cataract & Refractive Surgery Meeting - Julia Yu, BSc |
| 07/05/2023 21:40 | American Society of Cataract and Refractive Surgery Meeting - Steven Greenstein, MD |
| 06/05/2023 22:52 | The American Society of Cataract & Refractive Surgery Meeting - Ticiana De Francesco, MD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 237 241 -1.56% | 225 220 2.24% | 294 288 2.03% | 283 280 1.15% | 315 311 1.2% | 357 |
|
EBITDA Million USD | Released Forecast Spread | -44,0 -18,1 -143.47% | -94,2 -57,7 -63.28% | 7,83 -7,95 198.43% | -55,1 -51,6 -6.85% | -70,1 -71,2 1.48% | -74,9 |
|
EBIT Million USD | Released Forecast Spread | -50,3 -26,2 -92.01% | -48,2 -73,1 34.04% | -21,8 -26,5 17.46% | -86,7 -82,4 -5.27% | -104 -95,8 -8.38% | -98,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,0 -29,2 -71.65% | -132 -122 -8.68% | 0,00 0,00 - | 0,00 0,00 - | -134 -106 -26.23% | -105 |
|
Net income Million USD | Released Forecast Spread | 15,4 -28,3 154.58% | -120 -120 -0.31% | -49,6 -44,2 -12.16% | -99,2 -90,2 -9.95% | -135 -122 -10.36% | -113 |
|
EPS USD | Released Forecast Spread | 0,37 -0,72 151.19% | -2,70 -2,68 -0.81% | -1,07 -1,07 0.31% | -2,09 -1,93 -8.2% | -2,78 -2,59 -7.45% | -2,35 |
| Announcement Date | 27/02/20 | 25/02/21 | 22/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 73,2 67,3 8.88% | 67,7 60,9 11.22% | 72,7 68,0 6.91% | 71,3 68,0 4.87% | 71,2 68,1 4.64% | 73,9 67,7 9.1% | 80,4 74,7 7.68% | 78,0 75,3 3.7% | 82,4 78,5 4.88% | 79,7 | 87,5 | 89,9 | 99,8 | 98,0 |
|
EBITDA Million USD | Released Forecast Spread | -2,81 -11,6 75.75% | -6,03 -17,2 64.95% | -21,1 -14,0 -50.72% | -7,39 -13,5 45.03% | -19,2 -19,1 -0.72% | -18,5 -18,9 2.07% | -13,0 -17,4 25.41% | -13,3 -18,2 26.77% | -23,9 -20,0 -19.66% | -21,7 | -17,2 | -16,7 | -18,7 | -15,2 |
|
EBIT Million USD | Released Forecast Spread | -10,3 -15,1 31.86% | -13,6 -21,3 35.93% | -30,4 -17,9 -69.89% | -15,3 -20,7 26.2% | -27,4 -22,1 -24.14% | -26,8 -24,5 -9.23% | -22,8 -24,2 5.64% | -21,8 -23,9 8.71% | -32,4 -24,8 -30.4% | -27,4 | -23,5 | -23,0 | -23,8 | -20,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,2 -16,6 -34.19% | 5,70 -23,7 124.04% | -45,6 -21,8 -109.8% | -27,3 -24,7 -10.52% | -31,2 -25,9 -20.52% | -34,2 -26,3 -30.29% | -32,4 -26,0 -24.53% | -30,4 -26,4 -15.18% | -36,7 -26,2 -40.37% | -29,8 | -25,5 | -24,9 | -24,8 | -25,4 |
|
Net income Million USD | Released Forecast Spread | -21,9 -18,2 -20.49% | 5,38 -24,2 122.18% | -45,5 -23,0 -97.63% | -27,6 -25,6 -7.69% | -31,5 -26,6 -18.41% | -34,6 -28,9 -19.61% | -32,8 -28,9 -13.6% | -30,4 -28,2 -7.96% | -36,8 -28,8 -27.69% | -31,3 | -27,4 | -27,0 | -27,3 | -23,5 |
|
EPS USD | Released Forecast Spread | -0,47 -0,44 -8.05% | 0,11 -0,44 125.11% | -0,96 -0,52 -84.62% | -0,58 -0,54 -7.98% | -0,66 -0,55 -19.46% | -0,72 -0,60 -19.71% | -0,68 -0,60 -12.53% | -0,63 -0,60 -4.25% | -0,75 -0,61 -22.66% | -0,65 | -0,57 | -0,56 | -0,59 | -0,53 |
| Announcement Date | 22/02/22 | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 21/02/24 | - | - | - | - | - |
| 28/04/2024 | YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 28/04/2024 | BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
| 30/04/2024 21:05 | STRYKER CORPORATION: Q1 2024 Earnings Release |
| 30/04/2024 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
| 01/05/2024 07:00 | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 01/05/2024 21:05 | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | AXONICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 11:00 | ENOVIS CORPORATION: Q1 2024 Earnings Release |
| 05/05/2024 | ORTHOPEDIATRICS CORP.: Q1 2024 Earnings Release |
Past sector events for Glaukos Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GKOS Stock
- Calendar Glaukos Corporation
